Practical recommendations for screening of information on the drug safety
Active development of pharmacology in recent decades and the potential emergence of a large number of new drugs not only expanded the possibilities of treatment, but also increased the risk of adverse effects. That is the risk of severe, often irreversible complications due to drug therapy are attra...
Main Authors: | E. Yu. Pasternak, T. M. Bukatina, R. N. Alyautdin, B. K. Romanov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ministry of Health of the Russian Federation, Federal State Budgetary Institution «Scientific Centre for Expert Evaluation of Medicinal Products»
2018-02-01
|
Series: | Безопасность и риск фармакотерапии |
Subjects: | |
Online Access: | https://www.risksafety.ru/jour/article/view/52 |
Similar Items
-
Problems of Development of a Pharmacovigilance in Russia at the Present Stage (Review)
by: E. N. Khoseva, et al.
Published: (2018-06-01) -
Guidelines for the planning and implementation of pharmacovigilance systems audit
by: S. V. Glagolev, et al.
Published: (2018-02-01) -
Systemic characteristic of safety profile of monoclonal antibodies used in rheumatology practice
by: A. V. Philippova, et al.
Published: (2019-10-01) -
Monitoring post-approval drug safety in pregnancy: pharmacogenetic aspects
Published: (2018-02-01) -
Guidelines for the Preparation of a Document Containing the Drug Safety Monitoring Results
by: Yu. V. Olefir, et al.
Published: (2018-02-01)